What are the major opportunities in the Ankylosing Spondylitis market? What are the strategies for the Ankylosing Spondylitis market?

For detailed insights on the major opportunities and strategies in the Ankylosing Spondylitis market, Read More

How does the Ankylosing Spondylitis market relate to the overall economy and other similar markets?

For detailed insights on Ankylosing Spondylitis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Ankylosing Spondylitis market growth? SWOT analysis of the Ankylosing Spondylitis market.

For detailed insights on the key dynamics influencing the Ankylosing Spondylitis market growth and SWOT analysis of the Ankylosing Spondylitis industry, Read More

Ankylosing Spondylitis Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Ankylosing Spondylitis Market Report 2026

Name: Ankylosing Spondylitis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery), By Molecule (Biologics, Biosimilar, Small Molecules), By Route Of Administration (Parenteral, Oral, Other Routes), By Application (Juveniles, Adults), By End User (Hospitals, Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Ankylosing Spondylitis Market Overview

• Ankylosing Spondylitis market size has reached to $6.34 billion in 2025

• Expected to grow to $9.42 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%

• Growth Driver: Escalating Instances Of Autoimmune Diseases Propel The Ankylosing Spondylitis Market

• Market Trend: Regulatory Advancements Strengthening The Ankylosing Spondylitis Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ankylosing Spondylitis Market?

Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints (the joints connecting the lower spine to the pelvis). It involves inflammation of the joints and entheses and affects joints, leading to pain, stiffness, and progressive loss of mobility in the spine.

The main treatment of ankylosing spondylitis includes painkillers and non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biological therapies, steroids, and physical therapies, surgery. Painkillers and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) refer to medications that block the production of certain chemicals in the body that cause pain and swelling, which are used in ankylosing spondylitis treatment to relieve pain and reduce inflammation. Biologics, biosimilars, and small molecules are administered through parenteral, oral, and other routes for applications in juveniles and adults by hospitals, clinics, research laboratories, and other end users.

Ankylosing Spondylitis Market Global Report 2026 Market Report bar graph

What Is The Ankylosing Spondylitis Market Size and Share 2026?

The ankylosing spondylitis market size has grown strongly in recent years. It will grow from $6.34 billion in 2025 to $6.85 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to improved diagnostic awareness, wider availability of NSAIDs and DMARDs, increased specialist rheumatology services, expansion of hospital-based treatment access, growing use of imaging for disease monitoring.

What Is The Ankylosing Spondylitis Market Growth Forecast?

The ankylosing spondylitis market size is expected to see strong growth in the next few years. It will grow to $9.42 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising adoption of biologics and biosimilars, increasing focus on personalized medicine, expansion of advanced biologic pipelines, growing demand for long-term disease management, increasing investments in autoimmune research. Major trends in the forecast period include increasing adoption of biologic therapies, rising use of targeted DMARDs, growing focus on early disease diagnosis, expansion of personalized treatment approaches, enhanced integration of physical therapy programs.

Book your 30 minutes free consultation with our research experts

Global Ankylosing Spondylitis Market Segmentation

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

2) By Molecule: Biologics, Biosimilar, Small Molecules

3) By Route Of Administration: Parenteral, Oral, Other Routes

4) By Application: Juveniles, Adults

5) By End User: Hospitals, Clinics

Subsegments:

1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs, Prescription NSAIDs

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted DMARDs

3) By Biological Therapies: TNF Inhibitors, IL-17 Inhibitors

4) By Steroids: Oral Steroids, Injectable Steroids

5) By Physical Therapies: Physiotherapy, Exercise Programs

6) By Surgery: Joint Replacement Surgery, Spinal Surgery

What Is The Driver Of The Ankylosing Spondylitis Market?

The increase in instances of autoimmune diseases will boost the ankylosing spondylitis market going forward. Autoimmune diseases are a broad group of disorders characterized by an abnormal immune response in which the immune system mistakenly attacks and damages healthy cells, tissues, and organs. Autoimmune diseases, including ankylosing spondylitis, occur when the immune system mistakenly targets the body's own tissues, leading to inflammation and damage. Genetic predisposition and environmental factors contribute to the development of ankylosing spondylitis, a form of autoimmune arthritis primarily affecting the spine and pelvis. For instance, in September 2023, according to the Impact of IBD Report 2023 published by the IBD Clinical and Research Centre, a Canada-based organization that aims to improve the lives of patients with Crohn's disease and ulcerative colitis, with a prevalence of 825 per 100,000 in 2023, over 320,000 people in Canada have inflammatory bowel disease (IBD), and as the prevalence is expected to increase by 2.44% annually, 1.1% of the population, or 470,000 Canadians, is projected to be living with IBD by 2035. Therefore, the increase in instances of autoimmune diseases will drive the future growth of the ankylosing spondylitis industry.

Key Players In The Global Ankylosing Spondylitis Market

Major companies operating in the ankylosing spondylitis market are Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.

Global Ankylosing Spondylitis Market Trends and Insights

Major companies operating in the ankylosing spondylitis market are focusing on developing advanced biologic solutions, such as biosimilars, to enhance patient access, reduce treatment costs, and provide familiar administration options. Biosimilars are therapeutics that leverage established active ingredients of reference biologics while offering comparable efficacy and safety profiles. For instance, in August 2025, Amgen Biotechnology Singapore, a Singapore-based biotech firm, received approval for its biosimilar adalimumab (Amgevita) in both a 40 mg/0.4 mL autoinjector and a 20 mg/0.2 mL prefilled syringe. This therapy is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis who have had an inadequate response to conventional therapy. By providing familiar routes of administration, leveraging a well-known active ingredient, and offering a more affordable option in the biologics space.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Ankylosing Spondylitis Market?

In July 2023, Superior Biologics, Inc., a US-based specialty pharmacy and home infusion therapy service company, and Coherus BioSciences, Inc., announced a national distribution agreement. This partnership aims to provide nationwide distribution of YUSIMRY, a biosimilar of Humira, offering patients a high-quality, affordable treatment for conditions like ankylosing spondylitis, rheumatoid arthritis, and Crohn's disease, while helping employers reduce specialty drug costs by over 85%. Coherus BioSciences Inc. is a US-based biopharmaceutical company providing a biosimilar product for ankylosing spondylitis (AS) called YUSIMRY (adalimumab-aqvh).

Regional Outlook

North America was the largest region in the ankylosing spondylitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ankylosing Spondylitis Market?

The ankylosing spondylitis market consists of sales of nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs), tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and corticosteroids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ankylosing Spondylitis Market Report 2026?

The ankylosing spondylitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ankylosing spondylitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Ankylosing Spondylitis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.85 billion
Revenue Forecast In 2035	$9.42 billion
Growth Rate	CAGR of 8.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Molecule, Route Of Administration, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Ankylosing Spondylitis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Ankylosing Spondylitis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Ankylosing Spondylitis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Ankylosing Spondylitis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Biologic Therapies

4.2.2 Rising Use Of Targeted Dmards

4.2.3 Growing Focus On Early Disease Diagnosis

4.2.4 Expansion Of Personalized Treatment Approaches

4.2.5 Enhanced Integration Of Physical Therapy Programs

5. Ankylosing Spondylitis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Rheumatology Centers

5.4 Rehabilitation Centers

5.5 Research Laboratories

6. Ankylosing Spondylitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ankylosing Spondylitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Ankylosing Spondylitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Ankylosing Spondylitis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Ankylosing Spondylitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Ankylosing Spondylitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ankylosing Spondylitis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ankylosing Spondylitis Market Segmentation

9.1. Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

9.2. Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biologics, Biosimilar, Small Molecules

9.3. Global Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Parenteral, Oral, Other Routes

9.4. Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Juveniles, Adults

9.5. Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics

9.6. Global Ankylosing Spondylitis Market, Sub-Segmentation Of Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Over-The-Counter NSAIDs, Prescription NSAIDs

9.7. Global Ankylosing Spondylitis Market, Sub-Segmentation Of Disease-Modifying Anti-Rheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Conventional DMARDs, Targeted DMARDs

9.8. Global Ankylosing Spondylitis Market, Sub-Segmentation Of Biological Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

TNF Inhibitors, IL-17 Inhibitors

9.9. Global Ankylosing Spondylitis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Steroids, Injectable Steroids

9.10. Global Ankylosing Spondylitis Market, Sub-Segmentation Of Physical Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Physiotherapy, Exercise Programs

9.11. Global Ankylosing Spondylitis Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Joint Replacement Surgery, Spinal Surgery

10. Ankylosing Spondylitis Market Regional And Country Analysis

10.1. Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ankylosing Spondylitis Market

11.1. Asia-Pacific Ankylosing Spondylitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ankylosing Spondylitis Market

12.1. China Ankylosing Spondylitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ankylosing Spondylitis Market

13.1. India Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ankylosing Spondylitis Market

14.1. Japan Ankylosing Spondylitis Market Overview

14.2. Japan Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ankylosing Spondylitis Market

15.1. Australia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ankylosing Spondylitis Market

16.1. Indonesia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ankylosing Spondylitis Market

17.1. South Korea Ankylosing Spondylitis Market Overview

17.2. South Korea Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ankylosing Spondylitis Market

18.1. Taiwan Ankylosing Spondylitis Market Overview

18.2. Taiwan Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ankylosing Spondylitis Market

19.1. South East Asia Ankylosing Spondylitis Market Overview

19.2. South East Asia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ankylosing Spondylitis Market

20.1. Western Europe Ankylosing Spondylitis Market Overview

20.2. Western Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ankylosing Spondylitis Market

21.1. UK Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ankylosing Spondylitis Market

22.1. Germany Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ankylosing Spondylitis Market

23.1. France Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ankylosing Spondylitis Market

24.1. Italy Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ankylosing Spondylitis Market

25.1. Spain Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ankylosing Spondylitis Market

26.1. Eastern Europe Ankylosing Spondylitis Market Overview

26.2. Eastern Europe Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ankylosing Spondylitis Market

27.1. Russia Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ankylosing Spondylitis Market

28.1. North America Ankylosing Spondylitis Market Overview

28.2. North America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ankylosing Spondylitis Market

29.1. USA Ankylosing Spondylitis Market Overview

29.2. USA Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ankylosing Spondylitis Market

30.1. Canada Ankylosing Spondylitis Market Overview

30.2. Canada Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ankylosing Spondylitis Market

31.1. South America Ankylosing Spondylitis Market Overview

31.2. South America Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ankylosing Spondylitis Market

32.1. Brazil Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ankylosing Spondylitis Market

33.1. Middle East Ankylosing Spondylitis Market Overview

33.2. Middle East Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ankylosing Spondylitis Market

34.1. Africa Ankylosing Spondylitis Market Overview

34.2. Africa Ankylosing Spondylitis Market, Segmentation By Treatment Type, Segmentation By Molecule, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ankylosing Spondylitis Market Regulatory and Investment Landscape

36. Ankylosing Spondylitis Market Competitive Landscape And Company Profiles

36.1. Ankylosing Spondylitis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Ankylosing Spondylitis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Ankylosing Spondylitis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Ankylosing Spondylitis Market Other Major And Innovative Companies

Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.

38. Global Ankylosing Spondylitis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ankylosing Spondylitis Market

40. Ankylosing Spondylitis Market High Potential Countries, Segments and Strategies

40.1 Ankylosing Spondylitis Market In 2030 - Countries Offering Most New Opportunities

40.2 Ankylosing Spondylitis Market In 2030 - Segments Offering Most New Opportunities

40.3 Ankylosing Spondylitis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Ankylosing Spondylitis Market, Overview Of Key Products - Product Examples

Table 2: Global Ankylosing Spondylitis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Ankylosing Spondylitis Market, Supply Chain Analysis

Table 4: Global Ankylosing Spondylitis Market, Major Raw Material Providers

Table 5: Global Ankylosing Spondylitis Market, Major Resource Providers

Table 6: Global Ankylosing Spondylitis Market, Major Manufacturers (Suppliers)

Table 7: Global Ankylosing Spondylitis Market, Major Distributors And Channel Partners

Table 8: Global Ankylosing Spondylitis Market, Key Technologies & Future Trends

Table 9: Global Ankylosing Spondylitis Market, Major Trends

Table 10: Global Ankylosing Spondylitis Market, Major End Users

Table 11: Global Ankylosing Spondylitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Ankylosing Spondylitis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Ankylosing Spondylitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Ankylosing Spondylitis Market - TAM, US$ Billion, 2025

Table 15: Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Disease-Modifying Anti-Rheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Biological Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Physical Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Global Ankylosing Spondylitis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 101: Global Ankylosing Spondylitis Market - Company Scoring Matrix

Table 102: Pfizer Inc. Financial Performance

Table 103: Johnson & Johnson Pvt. Ltd. Financial Performance

Table 104: Merck & Co. Inc. Financial Performance

Table 105: AbbVie Inc. Financial Performance

Table 106: Novartis AG Financial Performance

Table 107: Global Ankylosing Spondylitis Market, Competitive Benchmarking (In USD Billions)

Table 108: Global Ankylosing Spondylitis Market, Competitive Dashboard

Table 109: Global Ankylosing Spondylitis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 110: Global, Ankylosing Spondylitis Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 111: Global, Ankylosing Spondylitis Market Size Gain ($ Billion), Segmentation By Molecule, 2025 – 2030

Table 112: Global, Ankylosing Spondylitis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Ankylosing Spondylitis Market, Overview Of Key Products - Product Examples

Figure 2: Global Ankylosing Spondylitis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Ankylosing Spondylitis Market, Supply Chain Analysis

Figure 4: Global Ankylosing Spondylitis Market, Major Raw Material Providers

Figure 5: Global Ankylosing Spondylitis Market, Major Resource Providers

Figure 6: Global Ankylosing Spondylitis Market, Major Manufacturers (Suppliers)

Figure 7: Global Ankylosing Spondylitis Market, Major Distributors And Channel Partners

Figure 8: Global Ankylosing Spondylitis Market, Key Technologies & Future Trends

Figure 9: Global Ankylosing Spondylitis Market, Major Trends

Figure 10: Global Ankylosing Spondylitis Market, Major End Users

Figure 11: Global Ankylosing Spondylitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Ankylosing Spondylitis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Ankylosing Spondylitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Ankylosing Spondylitis Market - TAM, US$ Billion, 2025

Figure 15: Global Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Ankylosing Spondylitis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Ankylosing Spondylitis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Disease-Modifying Anti-Rheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Biological Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Physical Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Ankylosing Spondylitis Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Ankylosing Spondylitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Ankylosing Spondylitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Ankylosing Spondylitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Ankylosing Spondylitis Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Ankylosing Spondylitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Global Ankylosing Spondylitis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 101: Global Ankylosing Spondylitis Market - Company Scoring Matrix

Figure 102: Pfizer Inc. Financial Performance

Figure 103: Johnson & Johnson Pvt. Ltd. Financial Performance

Figure 104: Merck & Co. Inc. Financial Performance

Figure 105: AbbVie Inc. Financial Performance

Figure 106: Novartis AG Financial Performance

Figure 107: Global Ankylosing Spondylitis Market, Competitive Benchmarking (In USD Billions)

Figure 108: Global Ankylosing Spondylitis Market, Competitive Dashboard

Figure 109: Global Ankylosing Spondylitis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 110: Global, Ankylosing Spondylitis Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 111: Global, Ankylosing Spondylitis Market Size Gain ($ Billion), Segmentation By Molecule, 2025 – 2030

Figure 112: Global, Ankylosing Spondylitis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Cervical Spondylosis Treatment Market Report 2026 - Global Outlook – By Type Of Treatment (Medications, Physical Therapy, Surgery), By Application (Youth, Elderly), By End User (Hospitals, Ambulatory Surgical Centers, Ho...

Axial Spondyloarthritis (axSpA) Market Report 2026 - Global Outlook – By Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA)), By Commercialized Therapies (Anti-Tumor Necrosis Factor Th...

Osteoarthritis Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Therapy), By Diagnosis (Imaging, Joint Fluid Analysis), By Route Of Administration (Parenteral Route, Topical Route, Oral Route), By...

Rare Inflammatory Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative...

Tendonitis Treatment Market Report 2026 - Global Outlook – By Treatment Type (Therapeutic Treatment, Hot And Cold Therapy, Physical Therapy, Shockwave Therapy, Surgical Treatment), By Condition Type (Tennis Elbow, Golfer...

Gouty Arthritis Market Report 2026 - Global Outlook – By Type (Acute Gouty Arthritis, Chronic Gouty Arthritis), By Treatment (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxida...

Osteoporosis Drugs Market Report 2026 - Global Outlook – By Type (Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors ), By Administration (Oral, Injectable), By Distribution Channel (...

Frequently Asked Questions

How big is the Ankylosing Spondylitis Market?

The Ankylosing Spondylitis market was valued at $6.34 billion in 2025, increased to $6.85 billion in 2026, and is projected to reach $9.42 billion by 2030. request a sample here

What is the Ankylosing Spondylitis market growth?

The global Ankylosing Spondylitis market is expected to grow at a CAGR of 8.3% from 2026 to 2035 to reach $9.42 billion by 2035. request a sample here

Who are the key players in Ankylosing Spondylitis market?

Some Key Players in the Ankylosing Spondylitis market Include, Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd. . request a sample here

What is the anticipated growth trend for the Ankylosing Spondylitis market?

Major trend in this market includes: Regulatory Advancements Strengthening The Ankylosing Spondylitis Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Ankylosing Spondylitis market?

North America was the largest region in the ankylosing spondylitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Ankylosing Spondylitis Market Report 2026 market?

Major companies operating in the Ankylosing Spondylitis Market Report 2026 market are Major companies operating in the ankylosing spondylitis market are Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd. request a sample here.

Which region has the most growth potential in the Ankylosing Spondylitis Market Report 2026 market?